150 related articles for article (PubMed ID: 31273859)
1. Validation of the Quality of Life Multiple Myeloma Module Questionnaire (QLQ-MY20) in Portuguese myeloma patients.
Graça Pereira M; Ferreira G; Pereira M; Faria S; Bacalhau R; Monteiro S; Fernandes B; Vilaça M
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13128. PubMed ID: 31273859
[TBL] [Abstract][Full Text] [Related]
2. Reliability and Validity of an Iranian Version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Multiple Myeloma: the EORTC QLQ-MY20.
Ahmadzadeh A; Yekaninejad MS; Saffari M; Pakpour AH; Aaronson NK
Asian Pac J Cancer Prev; 2016; 17(1):255-9. PubMed ID: 26838220
[TBL] [Abstract][Full Text] [Related]
3. Validity and reliability of the QLQ-MY20 module for assessing the health-related quality of life in Brazilians with multiple myeloma.
Malta JS; Silveira LP; Drummond PLM; Costa NL; Dos Santos RMM; Reis IA; Reis AMM; de Pádua CAM
Curr Med Res Opin; 2021 Jul; 37(7):1163-1169. PubMed ID: 33979261
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in multiple myeloma: clinical validation of the Mexican-Spanish version of the QLQ-MY20 instrument.
Espinoza-Zamora JR; Portilla-Espinosa CM; Labardini-Méndez JR; Cervera E; Niesvisky R; Oñate-Ocaña LF
Ann Hematol; 2015 Jun; 94(6):1017-24. PubMed ID: 25563595
[TBL] [Abstract][Full Text] [Related]
5. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
[TBL] [Abstract][Full Text] [Related]
6. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
Cocks K; Cohen D; Wisløff F; Sezer O; Lee S; Hippe E; Gimsing P; Turesson I; Hajek R; Smith A; Graham L; Phillips A; Stead M; Velikova G; Brown J;
Eur J Cancer; 2007 Jul; 43(11):1670-8. PubMed ID: 17574838
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study.
Dachs LR; Gaisán CM; Bustamante G; López SG; García EG; Persona EP; González-Calle V; Auzmendi MS; Pérez JMA; González Montes Y; Ríos Tamayo R; de Miguel Llorente D; Bernal LP; Mayol AS; Caro CC; Grande M; Fernández-Nistal A; Naves A; Miguel EMOS
Leuk Lymphoma; 2023; 64(11):1847-1856. PubMed ID: 37539698
[TBL] [Abstract][Full Text] [Related]
8. Use of the European Organisation for Research and Treatment of Cancer multiple myeloma module (EORTC QLQ-MY20): a review of the literature 25 years after development.
Forde K; Cocks K; Wells JR; McMillan I; Kyriakou C;
Blood Cancer J; 2023 May; 13(1):79. PubMed ID: 37193682
[TBL] [Abstract][Full Text] [Related]
9. Self-Reported Quality of Life and Symptom Burden in Ambulatory Patients With Multiple Myeloma on Disease-Modifying Treatment.
Kiely F; Cran A; Finnerty D; O'Brien T
Am J Hosp Palliat Care; 2017 Aug; 34(7):671-676. PubMed ID: 27141015
[TBL] [Abstract][Full Text] [Related]
10. Reliability and validity of the Greek QLQ-C30 and QLQ-MY20 for measuring quality of life in patients with multiple myeloma.
Kontodimopoulos N; Samartzis A; Papadopoulos AA; Niakas D
ScientificWorldJournal; 2012; 2012():842867. PubMed ID: 22919356
[TBL] [Abstract][Full Text] [Related]
11. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
Stead ML; Brown JM; Velikova G; Kaasa S; Wisløff F; Child JA; Hippe E; Hjorth M; Sezer O; Selby P
Br J Haematol; 1999 Mar; 104(3):605-11. PubMed ID: 10086801
[TBL] [Abstract][Full Text] [Related]
12. Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France.
Despiégel N; Touboul C; Flinois A; Saba G; Suzan F; Gonzalez-McQuire S; Bonnetain F
Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):e13-e28. PubMed ID: 30292736
[TBL] [Abstract][Full Text] [Related]
13. Validation of the caregiver oncology quality of life questionnaire in Portuguese caregivers of myeloma patients.
Pereira MG; Vilaça M; Pereira M; Bacalhau R; Monteiro S; Fernandes B; Faria S; Ferreira G
Palliat Support Care; 2020 Apr; 18(2):178-185. PubMed ID: 31317865
[TBL] [Abstract][Full Text] [Related]
14. Validation study of the Functional Assessment of Cancer Therapy-Cognitive Function-Version 3 for the Portuguese population.
Oliveira AF; Santos IM; Fernandes S; Bem-Haja P; Torres A
BMC Psychol; 2022 Dec; 10(1):305. PubMed ID: 36517827
[TBL] [Abstract][Full Text] [Related]
15. Health-Related Quality of Life and Satisfaction With Health Care: Relation to Clinical Stage in Mexican Patients With Multiple Myeloma.
Balderas-Peña LM; Miranda-Ruvalcaba C; Robles-Espinoza AI; Sat-Muñoz D; Ruiz MG; García-Luna E; Nava-Zavala AH; Rubio-Jurado B
Cancer Control; 2019; 26(1):1073274819831281. PubMed ID: 30786721
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires.
Ficko SL; Pejsa V; Zadnik V
Radiol Oncol; 2019 Sep; 53(3):337-347. PubMed ID: 31553711
[TBL] [Abstract][Full Text] [Related]
17. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
[TBL] [Abstract][Full Text] [Related]
18. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
19. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).
Weis J; Tomaszewski KA; Hammerlid E; Ignacio Arraras J; Conroy T; Lanceley A; Schmidt H; Wirtz M; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Czeladzki M; Harle A; Jones L; Ritter S; Flechtner HH; Bottomley A;
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376231
[TBL] [Abstract][Full Text] [Related]
20. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
